Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Glioblastoma × Clear all

Phase

Phase 3 3 Phase 1 3 Phase NA 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 329 INDUSTRY 101 NIH 42 NETWORK 20 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 48 Carcinoma, Non-Small-Cell Lung 29 Stomach Neoplasms 26 Colorectal Neoplasms 19 Small Cell Lung Carcinoma 17 Lung Neoplasms 16 Rectal Neoplasms 14 Neoplasm Metastasis 14 Pancreatic Neoplasms 12 Neoplasms 12 Esophageal Neoplasms 11 Ovarian Neoplasms 10 Nasopharyngeal Carcinoma 10 Uterine Cervical Neoplasms 9 Recurrence 9 Leukemia, Myeloid, Acute 9 Carcinoma, Hepatocellular 9 Melanoma 7 Lymphoma, Non-Hodgkin 7 Triple Negative Breast Neoplasms 6 Hodgkin Disease 6 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Colonic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Germ Cell and Embryonal 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Cholangiocarcinoma 5 Adenocarcinoma of Lung 5

Interventions

Temozolomide 1 Radiotherapy 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02029573 2017-08-18

ART

King Fahad Medical City

Phase 2 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡